These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Correlation among pathology, genotype, and patient outcomes in glioblastoma. Homma T; Fukushima T; Vaccarella S; Yonekawa Y; Di Patre PL; Franceschi S; Ohgaki H J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578 [TBL] [Abstract][Full Text] [Related]
11. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations. Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431 [TBL] [Abstract][Full Text] [Related]
12. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Kleinschmidt-DeMasters BK; Mulcahy Levy JM Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845 [TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutations in primary and secondary glioblastomas. Nonoguchi N; Ohta T; Oh JE; Kim YH; Kleihues P; Ohgaki H Acta Neuropathol; 2013 Dec; 126(6):931-7. PubMed ID: 23955565 [TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas. Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520 [TBL] [Abstract][Full Text] [Related]
16. Biomarker-based prognostic stratification of young adult glioblastoma. Zhang RQ; Shi Z; Chen H; Chung NY; Yin Z; Li KK; Chan DT; Poon WS; Wu J; Zhou L; Chan AK; Mao Y; Ng HK Oncotarget; 2016 Jan; 7(4):5030-41. PubMed ID: 26452024 [TBL] [Abstract][Full Text] [Related]
17. Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma. Picart T; Meyronet D; Pallud J; Dumot C; Metellus P; Zouaoui S; Berhouma M; Ducray F; Bauchet L; Guyotat J; ; J Cancer Res Clin Oncol; 2021 Jun; 147(6):1843-1856. PubMed ID: 33399987 [TBL] [Abstract][Full Text] [Related]
18. H3K27M mutation in adult cerebellar glioblastoma. Lu VM; Akinduro OO; Daniels DJ J Clin Neurosci; 2020 Jan; 71():316-317. PubMed ID: 31843430 [TBL] [Abstract][Full Text] [Related]
19. OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM). Zhou J; Shi LF; Wang Z; Li M; Zhang JS; Mao Y; Hua W Clinics (Sao Paulo); 2023; 78():100120. PubMed ID: 37001387 [TBL] [Abstract][Full Text] [Related]
20. Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters. Nakae S; Murayama K; Sasaki H; Kumon M; Nishiyama Y; Ohba S; Adachi K; Nagahisa S; Hayashi T; Inamasu J; Abe M; Hasegawa M; Hirose Y J Neurooncol; 2017 Jan; 131(2):403-412. PubMed ID: 27837434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]